Mavis Gezimati

Papers

Total Citations

145

H-Index

About

Mavis Gezimati is a leading researcher at the forefront of biomedical photonics and terahertz technology, with a primary focus on advancing non-invasive cancer diagnostics. Her most influential work, the 2022 paper "Advances in terahertz technology for cancer detection applications," has garnered 145 citations, establishing her as a key voice in translating terahertz spectroscopy from fundamental physics into clinical tools. Gezimati’s major contribution lies in systematically reviewing and refining terahertz imaging techniques to differentiate malignant from healthy tissues with high sensitivity, addressing critical challenges in early-stage cancer detection. Her research bridges gaps in signal processing, material characterization, and biophotonics, offering a roadmap for portable, label-free diagnostic devices. Beyond this landmark paper, Gezimati has published extensively on terahertz time-domain spectroscopy for skin and breast cancer analysis, earning recognition for her interdisciplinary approach that integrates engineering with medical needs. Her work not only highlights the potential of terahertz radiation for safe, real-time screening but also inspires new avenues for combining terahertz modalities with machine learning. For students and researchers, Gezimati exemplifies how targeted, high-impact reviews can shape an entire field, driving innovation from the lab bench toward clinical adoption.